Vanguard Group
JBIO

Vanguard Group’s Jade Biosciences JBIO Stock Holding History

Vanguard Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$32.3M Buy
2,095,767
+369,023
+21% +$4.33M ﹤0.01% 2400
2025
Q3 		$14.9M Sell
1,726,744
-80,838
-4% -$661K ﹤0.01% 2769
2025
Q2 		$18.1M Buy
1,807,582
+1,777,096
+5,829% +$60.5M ﹤0.01% 2601
2025
Q1 		$2.68M Buy
30,486
+1,860
+6% +$163K ﹤0.01% 3388
2024
Q4 		$2.66M Sell
28,626
-4,285
-13% -$369K ﹤0.01% 3482
2024
Q3 		$2.41M Buy
32,911
+1,331
+4% +$85.9K ﹤0.01% 3496
2024
Q2 		$1.83M Buy
31,580
+12,372
+64% +$8.21M ﹤0.01% 3587
2024
Q1 		$19.9M Buy
19,208
+1,299
+7% +$992K ﹤0.01% 2602
2023
Q4 		$14.2M Buy
17,909
+792
+5% +$404K ﹤0.01% 2761
2023
Q3 		$8.13M Buy
17,117
+2,158
+14% +$1.17M ﹤0.01% 3000
2023
Q2 		$8.98M Buy
14,959
+293
+2% +$187K ﹤0.01% 3007
2023
Q1 		$10.4M Buy
14,666
+395
+3% +$328K ﹤0.01% 2917
2022
Q4 		$14.6M Buy
14,271
+950
+7% +$690K ﹤0.01% 2781
2022
Q3 		$7.73M Buy
13,321
+681
+5% +$455K ﹤0.01% 3086
2022
Q2 		$6.92M Sell
12,640
-1,077
-8% -$514K ﹤0.01% 3193
2022
Q1 		$8.8M Buy
13,717
+337
+3% +$131K ﹤0.01% 3219
2021
Q4 		$5.52M Sell
13,380
-8,945
-40% -$4.52M ﹤0.01% 3551
2021
Q3 		$16.4M Buy
+22,325
New +$12.5M ﹤0.01% 2970

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group's JBIO Position: Q4 2025 in Review

Vanguard Group increased its Jade Biosciences (JBIO) stake by 21% in Q4 2025, buying an estimated $4.33M and bringing the position to 2,095,767 shares worth $32.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Vanguard Group first reported a position in JBIO in Q3 2021 and has held it in 18 quarters since. 105 funds tracked by Wall St. Rank hold JBIO as of Q4 2025.

  • Vanguard Group held 2,095,767 shares of Jade Biosciences worth $32.3M as of Q4 2025.
  • Vanguard Group bought 369,023 Jade Biosciences shares in Q4 2025, an estimated $4.33M.
  • Jade Biosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2400 holding.
  • Vanguard Group first reported a position in Jade Biosciences in Q3 2021 and has held it in 18 quarters since.
  • 105 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.